A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea
NCT02095158
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
440
Enrollment
INDUSTRY
Sponsor class
Conditions
Erythema
Rosacea
Interventions
DRUG:
Oxymetazoline HCL Cream 1.0%
Sponsor
Allergan